Miia Kivipelto
Researcher Next ID · RN-023465
Researcher · Medicine
Karolinska University Hospital
Stockholm, Sweden
- Works count
- 833
- Citation count
- 77,952
- H-index
- 108
- i10-index
- 365
Research interests
Publications
Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease
Nature Reviews Neurology · 2018 · 10.1038/s41582-018-0070-3
Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: The FINGER trial
Alzheimer s & Dementia · 2017 · 10.1016/j.jalz.2017.09.006
Body mass index and risk of dementia: Analysis of individual‐level data from 1.3 million individuals
Alzheimer s & Dementia · 2017 · 10.1016/j.jalz.2017.09.016
Defeating Alzheimer's disease and other dementias: a priority for European science and society
The Lancet Neurology · 2016 · https://doi.org/10.1016/s1474-4422(16)00062-4
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
Alzheimer s & Dementia · 2016 · https://doi.org/10.1016/j.jalz.2016.02.002
A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial
The Lancet · 2015 · https://doi.org/10.1016/s0140-6736(15)60461-5
Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies
International Journal of Geriatric Psychiatry · 2014 · 10.1002/gps.4245
Clinical trials and late‐stage drug development for A lzheimer's disease: an appraisal from 1984 to 2014
Journal of Internal Medicine · 2014 · 10.1111/joim.12191
The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): Study design and progress
Alzheimer s & Dementia · 2013 · https://doi.org/10.1016/j.jalz.2012.09.012
Nonpharmacological Therapies in Alzheimer’s Disease: A Systematic Review of Efficacy
Dementia and Geriatric Cognitive Disorders · 2010 · 10.1159/000316119
Alzheimer's disease: clinical trials and drug development
The Lancet Neurology · 2010 · https://doi.org/10.1016/s1474-4422(10)70119-8
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
BMJ · 2010 · 10.1136/bmj.b5465
Diabetes, Alzheimer disease, and vascular dementia
Neurology · 2010 · 10.1212/wnl.0b013e3181f4d7f8
Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease
Neurology · 2010 · 10.1212/wnl.0b013e3181d6476a
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention
Dialogues in Clinical Neuroscience · 2009 · 10.31887/dcns.2009.11.2/cqiu
Midlife Coffee and Tea Drinking and the Risk of Late-Life Dementia: A Population-Based CAIDE Study
Journal of Alzheimer s Disease · 2009 · 10.3233/jad-2009-0920
Midlife Serum Cholesterol and Increased Risk of Alzheimer’s and Vascular Dementia Three Decades Later
Dementia and Geriatric Cognitive Disorders · 2009 · 10.1159/000231980
Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study
The Lancet Neurology · 2006 · 10.1016/s1474-4422(06)70537-3
Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease
The Lancet Neurology · 2005 · 10.1016/s1474-4422(05)70198-8
Obesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease
Archives of Neurology · 2005 · 10.1001/archneur.62.10.1556
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
Journal of Internal Medicine · 2004 · https://doi.org/10.1111/j.1365-2796.2004.01380.x
Hippocampus and entorhinal cortex in mild cognitive impairment and early AD
Neurobiology of Aging · 2003 · 10.1016/s0197-4580(03)00084-8
Apolipoprotein E ε4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease
Annals of Internal Medicine · 2002 · 10.7326/0003-4819-137-3-200208060-00006
Midlife vascular risk factors and late-life mild cognitive impairment
Neurology · 2001 · 10.1212/wnl.56.12.1683
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study
BMJ · 2001 · https://doi.org/10.1136/bmj.322.7300.1447
Current projects
No projects listed.